Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $6.44 Million - $7.35 Million
111,514 Added 130.48%
196,976 $11.4 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $1.46 Million - $1.8 Million
-23,889 Reduced 21.85%
85,462 $5.32 Million
Q1 2023

May 15, 2023

SELL
$70.23 - $86.01 $3.54 Million - $4.33 Million
-50,362 Reduced 31.53%
109,351 $7.9 Million
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $420,748 - $526,780
-6,263 Reduced 3.77%
159,713 $12.8 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $6.41 Million - $8.03 Million
96,927 Added 140.37%
165,976 $11.1 Million
Q2 2022

Aug 15, 2022

BUY
$66.18 - $83.18 $29,714 - $37,347
449 Added 0.65%
69,049 $5.25 Million
Q1 2022

May 16, 2022

BUY
$66.02 - $79.71 $2.61 Million - $3.16 Million
39,600 Added 136.55%
68,600 $5.45 Million
Q4 2021

Feb 11, 2022

SELL
$63.34 - $74.11 $261,784 - $306,296
-4,133 Reduced 12.47%
29,000 $2.13 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $283,813 - $347,254
4,133 Added 14.25%
33,133 $2.28 Million
Q2 2021

Aug 16, 2021

BUY
$79.87 - $87.53 $2.32 Million - $2.54 Million
29,000 New
29,000 $2.44 Million
Q3 2020

Oct 26, 2020

SELL
$85.07 - $109.69 $348,787 - $449,729
-4,100 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $7.43 Million - $9.73 Million
-101,700 Reduced 96.12%
4,100 $358,000
Q3 2019

Oct 23, 2019

BUY
$72.82 - $86.52 $786,455 - $934,416
10,800 Added 11.37%
105,800 $7.85 Million
Q4 2018

Feb 14, 2019

SELL
$58.5 - $69.94 $1.76 Million - $2.1 Million
-30,000 Reduced 24.0%
95,000 $6.04 Million
Q3 2018

Nov 16, 2018

SELL
$61.75 - $74.23 $3.62 Million - $4.36 Million
-58,700 Reduced 31.95%
125,000 $8.64 Million
Q2 2018

Aug 15, 2018

BUY
$60.85 - $83.98 $225,145 - $310,726
3,700 Added 2.06%
183,700 $12.3 Million
Q1 2018

May 16, 2018

BUY
$83.06 - $100.98 $6.23 Million - $7.57 Million
75,000 Added 71.43%
180,000 $15 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $11.5 Million - $14.5 Million
105,000
105,000 $12.3 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.